09:03am Abbott introduces Ensure® Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop PR
08:14am Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target MT
10-05 Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities CI
10-05 Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor MT
10-05 Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition PR
10-05 Evercore ISI Adjusts Price Target on Abbott Laboratories to $124 From $120, Keeps Outperform Rating MT
10-02 Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119 MT
10-02 Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119 MT
09-30 Abbott Launches Simplescreen Crc Blood Test in the U.S CI
09-30 Abbott Launches SimpleScreen Blood Test for Colorectal Cancer MT
09-30 Abbott hosts conference call for third-quarter earnings PR
09-30 Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio PR
09-24 Abbott Laboratories : Landmark study in people with Type 2 diabetes using basal insulin shows continuous glucose monitoring, including Abbott’s Libre technology, associated with lower risk of death and cardiovascular complications PU
09-23 Abbott and Berry Street team up on personalized nutrition tracking Zonebourse
09-23 Abbott and Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health CI
09-23 Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health PR
09-18 Trinity Heart Experts First in the Quad Cities to Use New Afib Technology CI
09-17 Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026 CI
09-17 Abbott Laboratories Keeps Quarterly Dividend at $0.63 a Share, Payable Nov. 16 to Holders of Record on Oct. 15 MT
09-17 Abbott declares 411th consecutive quarterly dividend PR
09-15 Abbott Announces First Canadian Use of Volt Pulsed Field Ablation System to Treat Atrial Fibrillation CI
09-15 First Canadian Commercial Use of Abbott's Volt™ Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care AQ
09-15 Abbott to pay $385M over infant formula contamination probe AQ
09-14 Abbott agrees to settlement over closure of largest baby formula plant in the US AQ
09-14 Abbott Laboratories to Pay $385 Million to Settle Infant Formula Allegations MT
No results match your criteria